About Jaswinder Matharu
Form D filings for Nivagen Pharmaceuticals from 2020 to 2023 list Jaswinder Matharu as director.
Jaswinder Matharu first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Jaswinder Matharu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jaswinder Matharu works with at each company, as listed on that company's latest Form D.
Nivagen Pharmaceuticals, Inc. · Form D, Aug 11, 2023
DL
Dasaradhi Lakkaraju
Executive officer
GP
Gopal Patel
Executive officer
JS
Jwalant Shukla
CEO and director
RH
Rob Hart
Director
AS
Ashish Sevak
Director
PD
Praneel Deo
Executive officer
MK
Michael Kulper
Director